{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:46:53Z","timestamp":1793234813766,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.cgh.2017.08.027","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T23:32:02Z","timestamp":1504135922000},"page":"738-747.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5870-2310","authenticated-orcid":false,"given":"Louise","family":"China","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Maini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon S.","family":"Skene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainib","family":"Shabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Sylvestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain A.","family":"Colas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Becares Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Belloti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesmond","family":"Dalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek W.","family":"Gilroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2017.08.027_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/jhep.2002.30082","article-title":"Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis","volume":"35","author":"Fernandez","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.08.027_bib2","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/hep.25947","article-title":"Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience","volume":"56","author":"Bajaj","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.08.027_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.1840060217","article-title":"Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis","volume":"6","author":"Rajkovic","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.08.027_bib4","first-page":"129","article-title":"Lipopolysaccharide induced TNF production and monocyte human leucocyte antigen dr expression is correlated with survival in septic trauma patients","volume":"25","author":"Ploder","year":"2006","journal-title":"Shock"},{"key":"10.1016\/j.cgh.2017.08.027_bib5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm.3516","article-title":"Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2","volume":"20","author":"O'Brien","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.cgh.2017.08.027_bib6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1110\/ps.28702","article-title":"Structural insights into human serum albumin-mediated prostaglandin catalysis","volume":"11","author":"Yang","year":"2002","journal-title":"Protein Sci"},{"key":"10.1016\/j.cgh.2017.08.027_bib7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.22913","article-title":"Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality","volume":"50","author":"Jalan","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.08.027_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/00365520902719273","article-title":"Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"44","author":"Chen","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.08.027_bib9","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1111\/liv.12860","article-title":"Ischaemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis","volume":"35","author":"Giannone","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2017.08.027_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.smim.2015.03.004","article-title":"The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution","volume":"27","author":"Serhan","year":"2015","journal-title":"Semin Immunol"},{"key":"10.1016\/j.cgh.2017.08.027_bib11","doi-asserted-by":"crossref","first-page":"e010132","DOI":"10.1136\/bmjopen-2015-010132","article-title":"ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial","volume":"6","author":"China","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.cgh.2017.08.027_bib12","doi-asserted-by":"crossref","first-page":"C39","DOI":"10.1152\/ajpcell.00024.2014","article-title":"Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue","volume":"307","author":"Colas","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.cgh.2017.08.027_bib13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","article-title":"Human serum albumin, systemic inflammation, and cirrhosis","volume":"61","author":"Arroyo","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.08.027_bib14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jceh.2014.08.007","article-title":"Role of human albumin in the management of complications of liver cirrhosis","volume":"4","author":"Bernardi","year":"2014","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.cgh.2017.08.027_bib15","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.26338","article-title":"Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications","volume":"58","author":"Garcia-Martinez","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.08.027_bib16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jhep.2014.10.031","article-title":"Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure","volume":"62","author":"Garcia-Martinez","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.08.027_bib17","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2015.04.020","article-title":"Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: results of a pivotal pre-clinical study","volume":"63","author":"Lee","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.08.027_bib18","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jhep.2013.07.020","article-title":"Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study","volume":"59","author":"Simon-Talero","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.08.027_bib19","first-page":"66","article-title":"Progression of cirrhotic liver disease towards acute-on-chronic liver failure triggers changes in innate immune cell phenotype and their response to pro-inflammatory stimuli","author":"Maini","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.08.027_bib20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1042\/bj1300631","article-title":"Interaction of prostaglandins with blood plasma proteins","volume":"130","author":"Raz","year":"1972","journal-title":"Biochem J"},{"key":"10.1016\/j.cgh.2017.08.027_bib21","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.27322","article-title":"Posttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis","volume":"60","author":"Domenicali","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.08.027_bib22","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1097\/01.CCM.0000169876.14858.91","article-title":"Heterogeneity and oxidation status of commercial human albumin preparations in clinical use","volume":"33","author":"Bar-Or","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cgh.2017.08.027_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJMcibr1004371","article-title":"Immunotherapy for sepsis: a new approach against an ancient foe","volume":"363","author":"Hotchkiss","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2017.08.027_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.2106","article-title":"Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection","volume":"16","author":"Said","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.cgh.2017.08.027_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/CCM.0000000000002014","article-title":"Human sepsis eicosanoid and proresolving lipid mediator temporal profiles: correlations with survival and clinical outcomes","volume":"45","author":"Dalli","year":"2017","journal-title":"Crit Care Med"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651730993X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651730993X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:24:48Z","timestamp":1761542688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235651730993X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S154235651730993X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2017.08.027","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2017.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the AGA Institute","name":"copyright","label":"Copyright"}]}}